Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.

191.75 2.01 −1.04%
Market cap
$52.8B
P/E
57.8×
Fwd P/E
37.7×
Dividend yield
2.07%
F-score
7/9
Altman Z
1.84
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company 10-K filed Nov 25, 2025

Fiscal year 2025 · Period ended Sep 30, 2025 · Filed · accepted 4:27 PM ET · Document on sec.gov · Filing index

What changed

Item 7, Management’s Discussion and Analysis, against the 10-K filed Nov 27, 2024: 36 added · 38 removed · 85 modified; 25 with only figures updated

159 more changes in this Item, word by word, in Powerpack.

Powerpack